There are 2789 resources available
1623P - Phase I clinical trials (CT) forge on despite COVID-19
Presenter: Maria Julia Lostes Bardaji
Session: ePoster Display
1656P - Germline mutations in DNA damage repair genes in patients with small cell lung cancer
Presenter: Yu Feng
Session: ePoster Display
1657P - Anlotinib plus irinotecan or docetaxel in small-cell lung cancer (SCLC) relapsed within six months: Updated results from a single-arm phase II study
Presenter: Bing Xia
Session: ePoster Display
1627P - Management of locally advanced rectal cancer during the COVID-19 outbreak: First results of a shift towards short course neoadjuvant radiotherapy
Presenter: Bárbara Castro
Session: ePoster Display
1628P - Impact of COVID-19 pandemia on the diagnosis of breast cancer in one region of north of Portugal: One year experience
Presenter: Marta Vilaça
Session: ePoster Display
1629P - SARS-Cov-2 and Cancer Trials Ireland: Impact, resolution, legacy
Presenter: Seamus O'Reilly
Session: ePoster Display
1630P - The impact of the COVID-19 outbreak on surgical site infections in elective colorectal cancer surgery: One potential benefit of the pandemic?
Presenter: Francesk Mulita
Session: ePoster Display
1631P - Evaluation of the socio-sanitary and emotional impact caused by SARS-CoV-2 in a Spanish cohort of cancer patients after the second pandemic wave
Presenter: Daniel Herrero Rivera
Session: ePoster Display
1662P - Comprehensive analysis of the metabolic enzymes in patients with small cell lung cancer using a large-scale targeted proteomics assay
Presenter: Gouji Toyokawa
Session: ePoster Display
1663P - Prognostic impact of baseline neutrophil-to-lymphocyte ratio (NLR) and its change during treatment for overall survival in advanced SCLC
Presenter: MASASHI ISHIHARA
Session: ePoster Display